These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3480787)

  • 21. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
    Smith JA; Henry D; Ngui-Yen J; Castell A; Coderre S
    J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multilaboratory comparison of anaerobe susceptibility results using 3 different agar media.
    Roe DE; Finegold SM; Citron DM; Goldstein EJ; Wexler HM; Rosenblatt JE; Cox ME; Jenkins SG; Hecht DW
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S40-6. PubMed ID: 12173107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.
    Wasilauskas BL
    Diagn Microbiol Infect Dis; 1989; 12(1):39-43. PubMed ID: 2714071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species.
    Canawati HN
    Diagn Microbiol Infect Dis; 1989; 12(1):33-7. PubMed ID: 2714070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenem.
    Shungu DL; Weinberg E; Cerami AT
    J Clin Microbiol; 1985 Jun; 21(6):875-9. PubMed ID: 3859487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of anaerobic susceptibility results obtained by two methods of inoculum preparation.
    Bourgault AM; Lamothe F
    J Clin Microbiol; 1984 Dec; 20(6):1060-4. PubMed ID: 6520217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of susceptibility of anaerobic bacteria to beta-lactam antibiotics by a tablet diffusion test.
    Jansen JE; Bremmelgaard A
    APMIS; 1988 May; 96(5):464-70. PubMed ID: 3259887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values.
    Aldridge KE; Weeks LS; Stratton CW; Sanders CV
    Diagn Microbiol Infect Dis; 1990; 13(4):311-6. PubMed ID: 2076592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM; Finegold SM
    J Chemother; 1991 Feb; 3 Suppl 2():12-9. PubMed ID: 2040893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases.
    Esposito S; Galante D; Barba D; Pennucci C; Limauro D
    Microbiologica; 1985 Apr; 8(2):197-204. PubMed ID: 3874342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro activity of ceftizoxime on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Deforges L; Le Van Thoi J; Thabaut A; Meyran M; Chanal M; Cluzel M; Brun Y; Coulet M; Fleurette J
    Pathol Biol (Paris); 1984 May; 32(5):326-30. PubMed ID: 6330645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
    Sutter VL; Kirby B; Finegold SM
    Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria.
    Borobio MV; Pascual A; Dominguez MC; Perea EJ
    Antimicrob Agents Chemother; 1986 Oct; 30(4):626-7. PubMed ID: 3466569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter study of the in vitro antianaerobic activity of cefotetan compared with other antimicrobial agents.
    Zabransky RJ; Bobey DG; Sheikh W
    Am J Surg; 1988 May; 155(5A):47-51. PubMed ID: 3163901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycins.
    White RL; Kays MB; Friedrich LV; Del Bene VE
    J Antimicrob Chemother; 1993 Jan; 31(1):57-64. PubMed ID: 8444675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae.
    Jones RN; Fuchs PC; Washington JA; Gavan TL; Murray PR; Gerlach EH; Thornsberry C
    Diagn Microbiol Infect Dis; 1990; 13(6):499-507. PubMed ID: 2126232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of susceptibility of anaerobic bacteria to cefotetan and cefoxitin by the thioglycolate disk elution method.
    Barry AL; Packer RR
    J Clin Microbiol; 1984 Nov; 20(5):912-6. PubMed ID: 6595259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of susceptibility results of anaerobic organisms determined by agar dilution method and Sceptor Anaerobe MIC/ID Micro Broth Dilution Panels.
    Hussain Z; Lannigan R; Schieven BC; Stoakes L; Groves D
    Diagn Microbiol Infect Dis; 1987 Oct; 8(2):95-100. PubMed ID: 3427890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of susceptibilities of anaerobic bacteria determined by agar dilution and by a microbroth method.
    Baron EJ; Bruckner DA
    Rev Infect Dis; 1984; 6 Suppl 1():S249-53. PubMed ID: 6718938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.
    Sutter VL; Emmerman J; Randall E; Zabransky RJ; Birk RJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):424-6. PubMed ID: 3888103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.